Status and phase
Conditions
Treatments
About
SHIVA is a proof of concept randomized phase II trial which compares two treatment strategies for patients with refractory cancer.
From a tumor biopsy, a molecular profile of the disease is established (mutations, amplifications, hormone receptor status). If a molecular abnormality is identified for which an approved targeted agent is available, patients are randomized randomized between two arms:
A cross-over is proposed at disease progression.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Eligibility criteria for the randomized part :
Primary purpose
Allocation
Interventional model
Masking
742 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal